Cargando…

MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review

INTRODUCTION: Numerous therapeutic agents specifically targeting the mesenchymal-epithelial transition (MET) oncogene are being developed. OBJECTIVE: The aim of the current review was to systematically identify and analyze clinical trials that have evaluated MET inhibitors in various cancer types an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yiting, Xu, Jiachen, Sun, Boyang, Wang, Jie, Wang, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942886/ https://www.ncbi.nlm.nih.gov/pubmed/35266116 http://dx.doi.org/10.1007/s40291-021-00568-w

Ejemplares similares

Current status and progress in immunotherapy for malignant pleural mesothelioma
por: Sun, Boyang, et al.
Publicado: (2022)

Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors
por: Sun, Boyang, et al.
Publicado: (2023)

Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy
por: Zhao, Jie, et al.
Publicado: (2023)

MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis
por: Xu, Linrui, et al.
Publicado: (2022)

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer
por: Du, Jun, et al.
Publicado: (2021)

Targeting MET in cancer therapy
por: Mo, Hong-Nan, et al.
Publicado: (2017)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
por: Wang, Qiming, et al.
Publicado: (2019)

Biomarker development in MET-targeted therapy
por: Zhang, Yanni, et al.
Publicado: (2016)

A new chapter in immune checkpoint inhibitor therapy: starting with advanced lung squamous cell carcinoma
por: Fei, Kailun, et al.
Publicado: (2020)

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
por: Chiriaco, Cristina, et al.
Publicado: (2022)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

MET in glioma: signaling pathways and targeted therapies
por: Cheng, Fangling, et al.
Publicado: (2019)

Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review
por: Han, Zhaoguo, et al.
Publicado: (2017)

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer
por: Sun, Dantong, et al.
Publicado: (2023)

Clinical research evidence of cupping therapy in China: a systematic literature review
por: Cao, Huijuan, et al.
Publicado: (2010)

Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic review
por: Chen, Ruzhao, et al.
Publicado: (2023)

An Observatory for the MET Oncogene: A Guide for Targeted Therapies
por: Altintas, Dogus M., et al.
Publicado: (2023)

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
por: Huang, Xing, et al.
Publicado: (2020)

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
por: Lin, Xiaoting, et al.
Publicado: (2019)

Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2022)

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
por: Liang, Hongge, et al.
Publicado: (2020)

The Significance of MET Expression and Strategies of Targeting MET Treatment in Advanced Gastric Cancer
por: Liao, Haiyan, et al.
Publicado: (2021)

The Role of cMET in Gastric Cancer—A Review of the Literature
por: Van Herpe, Filip, et al.
Publicado: (2023)

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Peng, Lun-Xi, et al.
Publicado: (2021)

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022)

MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies
por: Rivas, Solange, et al.
Publicado: (2022)

Early Enteral Nutrition Met Calories Goals Led by Nurse on Improve Clinical Outcome: A Systematic Scoping Review
por: Koontalay, Apinya, et al.
Publicado: (2021)

Laparoscopic resection of benign schwannoma in the hepatoduodenal ligament: A case report and review of the literature
por: TAO, LIANG, et al.
Publicado: (2016)

ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors
por: Escorcia, Freddy E., et al.
Publicado: (2020)

Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
por: Zhang, Zhengchao, et al.
Publicado: (2022)

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer
por: Duan, Jianchun, et al.
Publicado: (2017)

Tumor-associated eosinophilia in a patient with EGFR-positive, MET-amplified lung adenocarcinoma refractory to targeted therapy: a case report and review of literature
por: Geng, Nan, et al.
Publicado: (2021)

Development of antibody-based c-Met inhibitors for targeted cancer therapy
por: Lee, Dongheon, et al.
Publicado: (2015)

Global Trends and Research Progress of Photodynamic Therapy in Skin Cancer: A Bibliometric Analysis and Literature Review
por: Sun, Jiachen, et al.
Publicado: (2023)

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies
por: Lau, Sally C.M., et al.
Publicado: (2023)

HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
por: Zhang, Hongli, et al.
Publicado: (2018)

Eurythmy Therapy in clinical studies: a systematic literature review
por: Büssing, Arndt, et al.
Publicado: (2008)

Novel Peptide CM 7 Targeted c-Met with Antitumor Activity
por: Xia, Chunlei, et al.
Publicado: (2020)

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells
por: Heukers, Raimond, et al.
Publicado: (2019)

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3unv9ne4thl3aq1bveas63q2ob